Clinical trial
Efficacy and Safety of Subcutaneous Immunoglobulin in Patients With Myasthenia Gravis
NCT04728425 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Subcutaneous Immunoglobulin in Patients With Myasthenia Gravis
- Lead sponsor
- University Health Network, Toronto
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 28, 2020
- Completion date
- December 30, 2023
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.